Dr Bob Feroli has been a pharmacist at Johns Hopkins Hospital for 38 years and has served as the Medication Safety Officer for past 12 years. In 2005, he established a Medication-Use Safety Pharmacy Residency (accredited by ASHP) from which nine residents have graduated. Four years ago Bob established the Armstrong Institute’s Medication Safety Clinical Community with the goal of sharing safety best practices among all six Johns Hopkins Hospitals.
Bob teaches on topics of safe medication-use practices and rational therapeutics. He is recognized as a distinguished faculty member by the Institute of Safe Medication Practices and helps to teach the ISMP Medication Safety Intensive program.
Previously, at Johns Hopkins Hospital, Bob was the Drug Information Pharmacist, Assistant Pharmacy Director of Clinical Services, established and directed the Investigational Drug Service, and served as an Interim Pharmacy Department Director.
Bob has consulted with14 international hospitals and 6 US hospitals. During these visits, Bob provides detailed consultation focusing on the Medication-Use system to improve safety, therapeutic appropriateness, efficiency (using Lean principles) and compliance with Joint Commission standards.
As healthcare continues to evolve, the practice of pharmacy must also evolve so that our patients can benefit from the unique expertise that pharmacists have to offer. Therapeutic drug regimens are becoming more plentiful, more complex, and more expensive. Now more than ever, pharmacy services across the entire continuum of care are needed to help optimize appropriate, safe and efficient therapeutic drug regimens. To continue meeting this challenge, a multipronged strategy is clearly necessary. These strategies, focusing on the core importance of pharmacy residency training, is the topic of this presentation.
An opportunity for you to interact and openly discuss the challenges faced in medication safety, and the key principles of how medication safety can be measured within the hospital setting. We will discuss the 5 attributes of a High Reliability Organisation (HRO), and consider examples of behaviours that we should all adopt to actually practice the attributes.
To organize the approach to measuring medication-use safety, the Donabedian conceptual model of Structure, Process, and Outcomes will be utilized. In this context, the pros and cons of utilizing incident reports as a measure of safety will be examined. In particular, the consequences of the non-rate based nature of incident reports will be put into perspective. Other related topics will also be discussed. These topics include a proactive approach to improving medication safety through the use of Failure Mode and Effects Analysis (FMEA) and a reactive approach through the use of Root Cause Analysis (RCA).